Heartflow highlights 2Q26 revenue up 48% YoY to $64.1 million in investor presentation

• Heartflow presented at the Wells Fargo Healthcare Conference, highlighting broad US adoption of its AI platform for coronary artery disease.
• 2Q26 revenue of $64.1 million, up 48% year over year; non-GAAP gross margin of 83.3%, up 7.7 points.
• US installed base of more than 1,465 sites as of Jan. 1, 2026; more than 35,000 active physician customers.
• Mid-term plan targets asymptomatic markets, citing a $6 billion US TAM expansion opportunity and 17.4 million addressable patients.
• 2026 milestones include a Category 1 CPT code effective Jan. 1, 2026; plaque staging launch in July; DECIDE 1-year data in November.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.